Javascript must be enabled to continue!
Abstract P3-13-06: Osteocytic Connexin 43 Hemichannels in Prevention of Bone Metastasis
View through CrossRef
Abstract
Bone metastases are major, potentially fatal complications in patients with advanced cancers including breast, prostate and lung cancers. The gap junction-forming protein connexin 43 (Cx43) has been known to inhibit primary tumor cell growth. In addition to gap junctions, Cx43 also forms halves of gap junctions known as hemichannels which allow communication between the intracellular and extracellular environments. Cx43 hemichannels in osteocytes have been shown to open when induced by mechanical stimulation as well as by treatment with alendronate (AD), an efficacious and commonly used bisphosphonate drug. The opening of hemichannels is known to release small molecules important for bone formation and remodeling. To confirm the opening of Cx43 hemichannels in the presence of AD, we measured uptake of ethidium bromide (EtBr) in MLO-Y4 cells after the addition of AD. As expected, an increase in Cx43 hemichannels EtBr uptake was observed after AD treatment. To elucidate the effect(s) of osteocyte Cx43 hemichannels on cancer cell growth and migration, we treated MLO-Y4 osteocytes with AD. Conditioned media (CM) was collected after treatment and were used to incubate with metastatic MDA-MB-231 breast cancer cells and PC3 prostate cancer cells. Cell migration was measured using wound healing and transwell migration assays, and cell proliferation was measured using the soft agarose anchorage-independent growth assay. The CM collected from MLO-Y4 osteocytes treated with AD reduced cancer cell migration and proliferation in a dose-dependent manner. However, direct treatment with AD had no effect on the cell migration or proliferation of the MDA-MB-231 cells. These data validated that the decrease in migration and proliferation was not a result of direct action by AD on the cancer cells. In order to elucidate the direct functional involvement of Cx43 hemichannels in cell migration, we treated the MLO-Y4 cells with Cx43 (E2) antibody, a specific antibody which blocks hemichannel activity but not gap junction channels formed by Cx43. The inhibitory effect of the CM on the migration and proliferation of MDA-MB-231 and PC3 cells was diminished. Interestingly, the inhibitory effects of osteocytes on cancer cell migration were not observed when using osteoblasts. Together, these results suggest the functional importance of osteocytic Cx43 hemichannels in attenuating cancer cell migration and growth.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P3-13-06.
Title: Abstract P3-13-06: Osteocytic Connexin 43 Hemichannels in Prevention of Bone Metastasis
Description:
Abstract
Bone metastases are major, potentially fatal complications in patients with advanced cancers including breast, prostate and lung cancers.
The gap junction-forming protein connexin 43 (Cx43) has been known to inhibit primary tumor cell growth.
In addition to gap junctions, Cx43 also forms halves of gap junctions known as hemichannels which allow communication between the intracellular and extracellular environments.
Cx43 hemichannels in osteocytes have been shown to open when induced by mechanical stimulation as well as by treatment with alendronate (AD), an efficacious and commonly used bisphosphonate drug.
The opening of hemichannels is known to release small molecules important for bone formation and remodeling.
To confirm the opening of Cx43 hemichannels in the presence of AD, we measured uptake of ethidium bromide (EtBr) in MLO-Y4 cells after the addition of AD.
As expected, an increase in Cx43 hemichannels EtBr uptake was observed after AD treatment.
To elucidate the effect(s) of osteocyte Cx43 hemichannels on cancer cell growth and migration, we treated MLO-Y4 osteocytes with AD.
Conditioned media (CM) was collected after treatment and were used to incubate with metastatic MDA-MB-231 breast cancer cells and PC3 prostate cancer cells.
Cell migration was measured using wound healing and transwell migration assays, and cell proliferation was measured using the soft agarose anchorage-independent growth assay.
The CM collected from MLO-Y4 osteocytes treated with AD reduced cancer cell migration and proliferation in a dose-dependent manner.
However, direct treatment with AD had no effect on the cell migration or proliferation of the MDA-MB-231 cells.
These data validated that the decrease in migration and proliferation was not a result of direct action by AD on the cancer cells.
In order to elucidate the direct functional involvement of Cx43 hemichannels in cell migration, we treated the MLO-Y4 cells with Cx43 (E2) antibody, a specific antibody which blocks hemichannel activity but not gap junction channels formed by Cx43.
The inhibitory effect of the CM on the migration and proliferation of MDA-MB-231 and PC3 cells was diminished.
Interestingly, the inhibitory effects of osteocytes on cancer cell migration were not observed when using osteoblasts.
Together, these results suggest the functional importance of osteocytic Cx43 hemichannels in attenuating cancer cell migration and growth.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P3-13-06.
Related Results
Connexin expression and gap junctional intercellular communication in human squamous cell carcinoma of the head and neck
Connexin expression and gap junctional intercellular communication in human squamous cell carcinoma of the head and neck
OBJECTIVEOur laboratory is investigating the role that gap junction intercellular channels (composed of proteins called connexins) play in communicating apoptotic signals from ther...
Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
Objectives: Bone morphogenetic proteins (BMPs) belong to the transforming growth factor superfamily that were first discovered by Marshall Urist. There are 14 BMPs identified to da...
The effect of miRNAs and MALAT1 related with the prognosis of Her-2 positive breast cancer patients with lymph node metastasis
The effect of miRNAs and MALAT1 related with the prognosis of Her-2 positive breast cancer patients with lymph node metastasis
Abstract
Background: To analyze and screen the miRNAs associated with lymph node metastasis of breast cancer (BC), and to explore the roles of these miRNAs in the prolifera...
OSTEOCYTIC REMODELING: QUESTION HISTORY MODERN REPRESENTATIONS AND POSSIBILITIES OF THE CLINICAL ESTIMATION
OSTEOCYTIC REMODELING: QUESTION HISTORY MODERN REPRESENTATIONS AND POSSIBILITIES OF THE CLINICAL ESTIMATION
The article discusses in a chronological order the terms used by different researchers during over 150 years to describe the phenomenon of osteocytic remodeling (halisteresis, onco...
Abstract 1490: Elucidating the effect of glutamine metabolism in breast to bone metastasis
Abstract 1490: Elucidating the effect of glutamine metabolism in breast to bone metastasis
Abstract
Bone-metastatic lesions will develop in approximately 65-75% of patients with metastatic breast cancer and are associated with high morbidity and mortality....
Myeloma Cell-Derived Runx2 Promotes Myeloma Progression and Bone-Homing
Myeloma Cell-Derived Runx2 Promotes Myeloma Progression and Bone-Homing
Abstract
Background. Multiple myeloma (MM), an incurable plasma-cell malignancy, preferentially grows in bone marrow and frequently metastasizes to new bone sites. T...
Abstract 1308: Protein profiling of breast cancer cell-derived extracellular vesicles in breast to bone metastasis
Abstract 1308: Protein profiling of breast cancer cell-derived extracellular vesicles in breast to bone metastasis
Abstract
Breast cancer is the most common cancer among women worldwide, with bone being one of the most common sites for breast cancer metastasis. Despite improvemen...
1. Morphological Implication on Cellular Response to Mechanical Stress in Bone
1. Morphological Implication on Cellular Response to Mechanical Stress in Bone
In bone, there are 3 distinct cell types: an osteoblast, a bone forming cell; an osteocyte embedded in bone matrix as a consequence of being differentiated from an osteoblast; and ...

